Avenue Therapeutics Stock Forecast - Price Action Indicator
| ATXI Stock | USD 1.85 0.05 2.78% |
Avenue Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Avenue Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Avenue |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.045 | 0.05 |
| Check Avenue Therapeutics Volatility | Backtest Avenue Therapeutics | Information Ratio |
Avenue Therapeutics Trading Date Momentum
| On December 20 2024 Avenue Therapeutics was traded for 1.84 at the closing time. The top price for the day was 1.84 and the lowest listed price was 1.80 . There was no trading activity during the period 0.0. Lack of trading volume on December 20, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.44% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Avenue Therapeutics to competition |
Other Forecasting Options for Avenue Therapeutics
For every potential investor in Avenue, whether a beginner or expert, Avenue Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Avenue Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Avenue. Basic forecasting techniques help filter out the noise by identifying Avenue Therapeutics' price trends.Avenue Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avenue Therapeutics stock to make a market-neutral strategy. Peer analysis of Avenue Therapeutics could also be used in its relative valuation, which is a method of valuing Avenue Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Avenue Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Avenue Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Avenue Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Avenue Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Avenue Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avenue Therapeutics shares will generate the highest return on investment. By undertsting and applying Avenue Therapeutics stock market strength indicators, traders can identify Avenue Therapeutics entry and exit signals to maximize returns.
Avenue Therapeutics Risk Indicators
The analysis of Avenue Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Avenue Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting avenue stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.39 | |||
| Standard Deviation | 4.51 | |||
| Variance | 20.37 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:Check out Historical Fundamental Analysis of Avenue Therapeutics to cross-verify your projections. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share 24.78 | Return On Assets (2.01) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.